Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma

International Journal of Oncology

Volumn 39, Issue 6, 2011, Pages 1391-1399

  Matsubara, Ryota ^a   Kawano, Shintaro ^a   Kiyosue, Takahiro ^a   Goto, Yuichi ^a   Hirano, Mitsuhiro ^a   Jinno, Teppei ^a   Toyoshima, Takeshi ^a   Kitamura, Ryoji ^a   Oobu, Kazunari ^a   Nakamura, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Np63; Immunohistochemistry; Malignant transformation; Oral leukoplakia; Oral squamous cell carcinoma

Indexed keywords

CYTOKERATIN 14; DELTANP63 PROTEIN; KI 67 ANTIGEN; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM DYSPLASIA; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHILD; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 80054802636     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1151     Document Type: Article

References (59)

1. Yang A, Kaghad M, Wang Y, et al.: p63, a p53 homolog at 3q-27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316, 1998. (Pubitemid 128379271)
2. Augustin M, Bamberger C, Paul D and Schmale H: Cloning and chromosomal mapping of the human p53-related KET gene to chromosome 3q27 and its murine homolog Ket to mouse chromosome 16. Mamm Genome 9: 899-902, 1998. (Pubitemid 28507203)
3. Trink B, Okami, Wu L, Sriuranpong V, Jen J and Sidransky D: A new human p53 homologue. Nat Med 4: 747-748, 1998.
4. Osada M, Ohba M, Kawahara C, et al.: Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 4: 839-843, 1998. (Pubitemid 28331028)
5. Jost CA, Marin MC and Kaelin WG: p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194, 1997. (Pubitemid 27400602)
6. Hagiwara K, McMenamin MG, Miura K and Harris CC: Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res 59: 4165-4169, 1999. (Pubitemid 29418718)
7. Bourdon JC, Fernandes K, Murray-Zmijewski F, et al.: p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19: 2122-2137, 2005. (Pubitemid 41330315)
8. Hibi K, Trink B, Patturajan M, et al.: AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97: 5462-5467, 2000. (Pubitemid 30313741)
9. Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K and Sidransky D: p53 associates with and targets Delta Np63 into a protein degradation pathway. Proc Natl Acad Sci USA 98: 1817-1822, 2001. (Pubitemid 32165581)
10. Patturajan M, Nomoto S, Sommer M, et al.: DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell 1: 369-379, 2002. (Pubitemid 41039138)
11. Stiewe T, Zimmermann S, Frilling A, Esche H and Putzer BM: Transactivation-deficient DeltaTA-p73 acts as anoncogene. Cancer Res 62: 3598-3602, 2002.
12. Wu G, Nomoto S, Hoque MO, et al.: DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 63: 2351-2357, 2003. (Pubitemid 36605166)
13. Yang A and McKeon F: P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1: 199-207, 2000.
14. Mills AA: p63: oncogene or tumor suppressor? Curr Opin Genet Dev 16: 38-44, 2006.
15. Yang A, Schweitzer R, Sun D, et al.: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718, 1999. (Pubitemid 29197650)
16. Pellegrini G, Dellambra E, Golisano O, et al.: p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 98: 3156-3161, 2001. (Pubitemid 32220815)
17. Barker N, Ridgway RA, van Es JH, et al.: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611, 2009.
18. Zhu L, Gibson P, Currle DS, et al.: Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457: 603-607, 2009.
19. Kramer IR, Lucas RB, Pindborg JJ and Sobin LH: Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46: 518-539, 1978. (Pubitemid 9056118)
20. Burkhardt A: Premalignant changes in the mouth mucosa. Proposals for nomenclature by an international expert commission. Pathologe 6: 126-132, 1985.
21. Schepman KP, Van Der Meij EH, Smeele LE and van Der Waal I: Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 34: 270-275, 1998. (Pubitemid 28318253)
22. Nylander K, Coates PJ and Hall PA: Characterization of the expression pattern of p63α and ΔN-p63 in benign and malignant oral epithelial lesions. Int J Cancer 87: 368-372, 2000. (Pubitemid 30451647)
23. Chen YK, Huse SS and Lin LM: Differential expression of p53, p63, and p73 proteins in human buccal squamous cell carcinomas. Clin Otolaryngol 28: 451-455, 2003. (Pubitemid 37188163)
24. Chen YK, Huse SS and Lin LM: Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal pouch squamous cell carcinogenesis. Oral Diseases 9: 235-240, 2003. (Pubitemid 37051526)
25. Pruneri G, Pignataro L, Manzotti M, et al.: p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 downregulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity. Lab Invest 82: 1327-1334, 2002. (Pubitemid 35191536)
26. Glickman JN, Yang A, Shahsafaei A, Mckeon F and Odze RD: Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol 32: 1157-1165, 2001. (Pubitemid 33104425)
27. Geddert H, Kiel S, Heep HJ, Gabbert HE and Sarbia M: The role of p63 and deltaNp63 (p40) protein expression and gene ampli- fication in esophageal carcinogenesis. Hum Pathol 34: 850-856, 2003. (Pubitemid 37169613)
28. Massion PP, Taflan PM, Jamshedur SM, et al.: Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res 63: 7113-7121, 2003. (Pubitemid 37413448)
29. Gale N, Pilch BZ, Sindramsky D, et al.: Epithelial precursor lesions. In: World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. Barnes L, Eveson J, Reichart P and Sidransky D (eds). Iarc Press, Lyon, pp177-179, 2005.
30. Wahi PN, Cohen B, Luthra UK, et al.: Histological consideration. In: Histological Typing of Oral and Oropharyngeal tumors. Wahi PN, Cohen B, Luthra UK, et al. (eds). World Health Organization, Geneva, pp15-19, 1977.
31. Sobin LH, Witte Sobin LH and Wittekind Ch (eds). TNM Classification of Malignant Tumors. Wiley-Liss, Inc., New York, NY, 2002.
32. Yamamoto E, Miyakawa A and Kohama G: Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg 6: 938-947, 1984. (Pubitemid 14148096)
33. Fuchs E and Segre JA: Stem cells: a new lease on life. Cell 100: 143-155, 2000. (Pubitemid 30046303)
34. Watt FM and Hogan BL: Out of Eden: stem cells and their niches. Science 287: 1427-1430, 2000. (Pubitemid 30127126)
35. Lehrer MS, Sun TT and Lavker RM: Strategies of epithelial repair: modulation of stem cell and transit amplifying cell proliferation. J Cell Sci 111: 2867-2875, 1998. (Pubitemid 28495194)
36. Morris RJ and Potten CS: Slowly cycling (label-retaining) epidermal cells behave like clonogenic stem cells in vitro. Cell Prolif 27: 279-289, 1994. (Pubitemid 24148610)
37. Morris RJ and Potten CS: Highly persistent label-retaining cells in the hair follicles of mice and their fate following induction of anagen. J Invest Dermatol 112: 470-475, 1999. (Pubitemid 29171937)
38. Taylor G, Lehrer MS, Jensen PJ, Sun TT and Lavker RM: Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102: 451-461, 2000.
39. Cotsarelis G, Cheng SZ, Dong G, Sun TT and Lavker RM: Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell 57: 201-209, 1989. (Pubitemid 19112360)
40. Takeda T, Sugihara K, Hirayama Y, Hirano M, Tanuma JI and Semba I: Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias. J Oral Pathol Med 35: 369-375, 2006. (Pubitemid 43880174)
41. Chen YK, Hsue SS and Lin LM: Expression of p63 protein and mRNA in oral epithelial dysplasia. J Oral Pathol Med 34: 232-239, 2005.
42. Vered M, Allon I and Dayan D: Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma. Oral Pathol Med 38: 314-320, 2009.
43. Koster MI and Roop DR: The role of p63 in development and differentiation of the epidermis. J Dermatol Sci 34: 3-9, 2004. (Pubitemid 38134467)
44. Koster MI, Kim S, Mills AA, De Mayo FJ and Roop DR: p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18: 126-131, 2004. (Pubitemid 38141780)
45. Candi E, Rufini A, Terrinoni A, et al.: Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 13: 1037-1047, 2006.
46. Romano RA, Birkaya B and Sinha SJ: A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63. J Invest Dermatol 127: 1175-1186, 2007. (Pubitemid 46625134)
47. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA and El-Naggar AK: Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 33: 158-164, 2002. (Pubitemid 34298729)
48. Wang BY, Gil J, Kaufman D, Gan L, Kohtz DS and Burstein DE: p63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 33: 921-926, 2002.
49. Lo Muzio L, Santarelli A, Caltabiano R, et al.: p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 36: 187-194, 2005. (Pubitemid 40313576)
50. Tsujita-Kyutoku M, Kiuchi K, Danbara N, Yuri T, Senzaki H and Tsubura A: p63 expression in normal human epidermis and epidermal appendages and their tumors. J Cutan Pathol 30: 11-17, 2003. (Pubitemid 36152767)
51. Crook T, Nicholls JM, Brooks L, O'Nions J and Allday MJ: High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19: 3439-3444, 2000. (Pubitemid 30479339)
52. Moergel M, Abt E, Stockinger M and Kunkel M: Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma. Oral Oncol 46: 667-671, 2010.
53. Oliveira LR, Ribeiro-Silva A and Zucoloto S: Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med 36: 191-197, 2007. (Pubitemid 46495983)
54. Oliveira LR, Ribeiro-Silva A, Costa JP, Simões AL, Matteo MA and Zucoloto S: Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106: 685-695 2008.
55. Takahashi Y, Noguchi T, Takeno S, Kimura Y, Okubo M and Kawahara K: Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Oncol Rep 15: 323-328, 2006.
56. Foschini MP, Gaiba A, Cocchi R, et al.: Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 444: 332-339, 2004. (Pubitemid 38553637)
57. Barbieri CE, Tang LJ, Brown KA and Pietenpol JA: Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res 66: 7589-7597, 2006. (Pubitemid 44289215)
58. Cavallaro U: N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr Opin Investig Drugs 5: 1274-1278, 2004.
59. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S and Nagayama M: Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 94: 593-597, 2003. (Pubitemid 36975013)